Long-acting reversible contraception

Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception

Status: History
Publication date: October 2005
Wave: 7
Process: CG
Topic area:
  • Gynaecology, pregnancy and birth
  • Public health
  • Therapeutic procedures
 

NICE project team

Centre for clinical practice lead: Andrew Dillon
Communications manager: Lucy Betterton
Guidelines commissioning manager: Wendy Riches
Guidelines coordinator: Bobbie Lloyd
Patient involvement lead: Victoria Thomas
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email contraception@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 01 September 2002
Consultation on draft scope with stakeholders: 27 August - 24 September 2002
Submission Date: 01 September 2003
Consultation on draft guideline with stakeholders: 7 March - 5 April 2005
Consultation on final draft of guidance: 23 May - 17 June 2005
Pre-publication check: TBC
Publication date: October 2005
Top


 

Project history

Date Update
20 May 2002 The remit for this guideline was received from the Department of Health and Welsh Assembly Government.
9 July 2002 Provisional schedule updated.
6 August 2002 List of stakeholders added.
10 January 2003 The scope (see links below) defines what aspects of care are covered by the guideline and to whom it applies.)
Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table (see links below).
22 October 2003 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Three versions of the guideline are under preparation: a full guideline, a NICE short-form guideline and information for the public. Please see timescales above for dates of the first and final rounds of consultation with stakeholders.
9 February 2004 List of Guideline Development Group (GDG) members added.
5 April 2004 Patient Involvement Lead added.
6 July 2004 List of stakeholders updated.
27 July 2004 Provisional schedule and expected date of issue updated.
13 August 2004 Provisional schedule updated; list of stakeholders updated.
6 October 2004 List of stakeholders updated.
8 October 2004 Contact details updated.
2 November 2004 List of stakeholders updated.
21 December 2004 List of stakeholders updated.
5 January 2005 Expected date of issue amended and consultation date published.
9 February 2005 List of stakeholders updated.
7 March 2005 The first consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.
6 April 2005 Consultation on the first consultation draft of the guideline is complete and the guideline is being modified in the light of comments received. Please see timescales above for the dates of the final round of consultation with stakeholders.
22 April 2005 List of stakeholders updated.
23 May 2005 The final consultation draft of the guideline (please see link below) is out for consultation. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.
9 June 2005 List of stakeholders updated.
22 June 2005 Consultation on the final consultation draft of the guideline is complete and the guideline is being modified in the light of comments received.
Top


 

Key documents

This page was last updated: 30 March 2010